SEC
SlamSEC
SearchBrowseEarnings

AYTU BIOPHARMA, INC

Nasdaq:AYTU
Pharmaceutical Preparations·DENVER, CO
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(890 total)

TypeDateAccessionPeriodSize
SCHEDULE 13G/A
Feb 17, 2026
0000935836-26-000109
—
12.5 KB
SCHEDULE 13G/A
Feb 13, 2026
0001535264-26-000010
—
8.0 KB
10-Q
Feb 3, 2026
0001437749-26-002804FORM 10-Q
Dec 31, 2025
8.5 MB
8-K
Feb 3, 2026
0001437749-26-002799FORM 8-K
Feb 3, 2026
396.6 KB
8-K
Jan 20, 2026
0001437749-26-001543FORM 8-K
Jan 20, 2026
11.5 MB
8-K
Dec 10, 2025
0001437749-25-037389FORM 8-K
Dec 10, 2025
183.7 KB
SCHEDULE 13G/A
Nov 14, 2025
0000935836-25-000682
—
12.2 KB
10-Q
Nov 13, 2025
0001437749-25-034825FORM 10-Q
Sep 30, 2025
7.6 MB
8-K
Nov 13, 2025
0001437749-25-034822FORM 8-K
Nov 13, 2025
361.4 KB
SCHEDULE 13G/A
Nov 12, 2025
0001193805-25-001566
—
13.9 KB
ARS
Oct 24, 2025
0001437749-25-031722ARS
Jun 30, 2025
1.1 MB
DEFA14A
Oct 24, 2025
0001437749-25-031720FORM DEFA14A
—
1.3 MB
DEF 14A
Oct 24, 2025
0001437749-25-031719FORM DEF 14A
Dec 10, 2025
2.6 MB
5
Oct 20, 2025
0000912282-25-001096
Jun 30, 2025
8.2 KB
4
Oct 7, 2025
0001437749-25-030650FORM 4
Oct 3, 2025
15.4 KB
4
Oct 7, 2025
0001437749-25-030648FORM 4
Oct 3, 2025
16.7 KB
4
Oct 7, 2025
0001437749-25-030645FORM 4
Oct 3, 2025
16.7 KB
4
Oct 7, 2025
0001437749-25-030642FORM 4
Oct 3, 2025
17.1 KB
4
Oct 7, 2025
0001437749-25-030639FORM 4
Oct 3, 2025
15.0 KB
4
Oct 7, 2025
0001437749-25-030636FORM 4
Oct 3, 2025
15.1 KB
4
Oct 7, 2025
0001437749-25-030634FORM 4
Oct 3, 2025
15.4 KB
4
Oct 7, 2025
0001437749-25-030632FORM 4
Oct 3, 2025
15.0 KB
S-8
Sep 23, 2025
0001437749-25-029726FORM S-8
—
259.0 KB
10-K
Sep 23, 2025
0001437749-25-029723FORM 10-K
Jun 30, 2025
11.9 MB
8-K
Sep 23, 2025
0001437749-25-029721FORM 8-K
Sep 23, 2025
435.9 KB
25 filings shown
CEO
Disbrow Joshua R.
CFO
Selhorn Ryan J